About Clonz Biotech P. Ltd
Clonz Biotech P. Ltd is a leading biosimilar research and manufacturing company that was founded in 2010 by a team of experienced leaders in the field. The company operates from Genome Valley, Hyderabad, India and has been exclusively focused on developing biosimilar therapeutic monoclonal antibodies (MABs).
The team at Clonz Biotech is dedicated to providing high-quality biosimilars that are affordable and accessible to patients worldwide. They have a deep understanding of the complex science behind biologics and use their expertise to develop innovative solutions for patients suffering from various diseases.
One of the key strengths of Clonz Biotech is its state-of-the-art manufacturing facility that adheres to strict quality standards. The facility is equipped with advanced technology and equipment that enables the production of high-quality biosimilars at scale.
The company's portfolio includes several biosimilar products such as Trastuzumab, Rituximab, Adalimumab, Bevacizumab, Etanercept, Infliximab, and more. These products have been developed using advanced technologies such as cell line development, process optimization, analytical characterization, and clinical trials.
Clonz Biotech's commitment to quality has earned it several certifications including ISO 9001:2015 certification for Quality Management Systems (QMS), ISO 14001:2015 certification for Environmental Management Systems (EMS), OHSAS 18001:2007 certification for Occupational Health & Safety Management Systems (OHSMS), WHO-GMP certification for Good Manufacturing Practices (GMP) compliance.
In addition to its focus on research and development of biosimilars, Clonz Biotech also places great emphasis on sustainability practices. The company has implemented several initiatives aimed at reducing its carbon footprint such as energy-efficient lighting systems in its facilities.
Overall, Clonz Biotech P. Ltd is a leading player in the field of biosimilar research and manufacturing with a strong commitment to quality and sustainability practices. Its innovative solutions have helped improve access to affordable healthcare globally while maintaining high standards of safety and efficacy.